GENERIC NAME OF THE MEDICINAL PRODUCT:
B. Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.2mg+80mg+500mg)
C. Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.3mg+80mg+500mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each uncoated Bilayered tablet contains:
Voglibose IP………………………………………0.2mg
Gliclazide IP………………………………………40mg
Metformin Hydrochloride IP…………….500mg
(As Sustained Release Form)
Excipients………………………………………q.s
Colour: Ponceau 4R Lake
B) Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.2mg+80mg+500mg)
Each uncoated Bilayered tablet contains:
Voglibose IP………………………………………0.2mg
Gliclazide IP………………………………………80mg
Metformin Hydrochloride IP…………….500mg
(As Sustained Release Form)
Excipients………………………………………q.s
Colour: Sunset Yellow FCF
C) Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.3mg+80mg+500mg)
Each uncoated Bilayered tablet contains:
Voglibose IP………………………………………0.3mg
Gliclazide IP………………………………………80mg
Metformin Hydrochloride IP…………….500mg
(As Sustained Release Form)
Excipients………………………………………q.s
Colour: Quinoline Yellow WS
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
SCHEDULE G PRESCRIPTION DRUG-CAUTION: It is dangerous to take the prescription except under medical supervision.
SCHEDULE H PRESCRIPTION DRUG-WARNING: To be sold by retail on the prescription of a registered medical practitioner only.
STORAGE & DOSAGE:
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.
Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.2mg+40mg+500mg) Technical Specification:
| Product Name: | Voglibose + Gliclazide + Metformin Hydrochloride Tablets |
| Brand Name: | Generic |
| Strength: | (0.2mg+40mg+500mg), (0.2mg+80mg+500mg), (0.3mg+80mg+500mg) |
| Dosage Form: | Tablets (uncoated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10 strips of 10 tablets each |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antidiabetic |
| Indication: | GLICLAZIDE+METFORMIN+VOGLIBOSE belongs to a class of medicine known as an antidiabetic primarily indicated in the treatment of type 2 diabetes mellitus. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose. |
| Storage: | Store at temperature not exceeding 30℃. Store in cool, dry & dark place. Protect from Light & moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.2mg+40mg+500mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.2mg+40mg+500mg)
Each uncoated Bilayered tablet contains:
Voglibose IP………………………………………0.2mg
Gliclazide IP………………………………………40mg
Metformin Hydrochloride IP…………….500mg
(As Sustained Release Form)
Excipients………………………………………q.s
Colour: Ponceau 4R Lake
THERAPEUTIC INDICATIONS:
GLICLAZIDE+METFORMIN+VOGLIBOSE belongs to a class of medicine known as an antidiabetic primarily indicated in the treatment of type 2 diabetes mellitus. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose.
CAUTION & SCHEDULE:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
SCHEDULE G PRESCRIPTION DRUG-CAUTION: It is dangerous to take the prescription except under medical supervision.
SCHEDULE H PRESCRIPTION DRUG-WARNING: To be sold by retail on the prescription of a registered medical practitioner only.
STORAGE & DOSAGE:
Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.
Introduction to Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.2mg+40mg+500mg)
What It Is and How It Helps Manage Type 2 Diabetes
This combination tablet is a comprehensive oral diabetes management therapy, designed for patients who cannot achieve optimal blood sugar control using monotherapy or dual therapy. It targets different pathways of glucose metabolism, offering:
✔ Better postprandial glucose (PPG) control
✔ Improved fasting blood sugar (FBS) values
✔ Overall HbA1c reduction
✔ Lower risk of long-term diabetes complications
How to Use the Medication
As recommended with all anti-diabetic tablets:
-
It should be taken with food, preferably at the same time daily.
-
Patients must follow their doctor’s prescribed dosage.
-
Stopping the medicine suddenly may increase blood sugar and risk complications, such as:
-
kidney damage
-
nerve dysfunction
-
blindness
-
limb amputation
-
This medication must be paired with a healthy diet, weight management, and exercise. Taj Pharma ensures therapeutic consistency so patients can rely on stable blood glucose control.
Global Demand Overview
With diabetes topping global disease charts, this triple therapy is in high demand across:
-
Africa (Nigeria, Kenya, Ghana, Tanzania)
-
Middle East (Saudi Arabia, UAE, Oman, Iraq)
-
Southeast Asia (Philippines, Myanmar, Vietnam)
-
Latin America (Peru, Bolivia, Colombia)
-
CIS regions (Uzbekistan, Georgia, Kazakhstan)
Its affordability and clinical efficacy make it a preferred choice for healthcare systems and global distributors.
In-Depth Details for Importers, Exporters & Buyers
Taj Pharma stands out as a reliable partner for pharmaceutical importers due to its robust compliance standards, export readiness, and transparent regulatory support.
Comprehensive Regulatory Documentation Provided
Taj Pharma offers full regulatory backup, including:
-
WHO-GMP Certificate
-
COPP (Certificate of Pharmaceutical Product)
-
FSC (Free Sale Certificate)
-
Manufacturing License & GMP audit reports
-
CTD/ACTD Dossiers
-
Stability Studies (Zone II–IV)
-
Batch Manufacturing Records
-
Certificate of Analysis (COA)
-
MOH compliance documentation
This extensive support helps buyers accelerate registration and market launch.
Custom Packaging & Labeling Options
To help global distributors meet diverse regulatory and branding requirements, Taj Pharma provides:
-
Export-grade blister and Alu-Alu packaging
-
Private labeling with custom artwork
-
Multilingual labeling (English, French, Arabic, Spanish, Russian)
-
Moisture-protective packaging for tropical climates
-
Custom pack sizes for tenders, hospitals, and retail chains
Shelf-Life, Storage & Dosage Form
-
Dosage Form: Film-coated tablets
-
Strength: 0.2mg + 40mg + 500mg
-
Shelf-life: 24–36 months depending on target country
-
Storage Conditions:
-
Store at <25°C
-
Protect from light & moisture
-
-
Packaging:
-
10×10 strips
-
100–1000 tablets bulk supply
-
Alu-Alu blister packs
-
Export Certifications
Every batch meets international quality and regulatory standards:
✔ WHO-GMP
✔ ISO 9001:2015
✔ GLP-compliant testing
✔ Free Sale Certificate (FSC)
✔ COPP for rapid registration
✔ CTD Dossiers for global tenders
Target Countries & Export Markets
Taj Pharma exports this combination therapy to:
-
African nations: Kenya, Ethiopia, Ghana, Zambia, Rwanda
-
Middle East: Saudi Arabia, UAE, Yemen, Iraq
-
Asia: Sri Lanka, Philippines, Myanmar, Nepal
-
CIS: Kazakhstan, Georgia, Uzbekistan
-
LATAM: Peru, Ecuador, Bolivia
Why Taj Pharma is the Most Trusted Manufacturer, Supplier & Exporter
1. Ultra-Modern WHO-GMP Manufacturing Unit
The Vapi facility is equipped with:
-
High-speed tablet compression machines
-
Automated coating systems
-
Validated manufacturing processes
-
Dust-free cleanrooms
-
Precision QC/QA labs
-
Microbial testing units
Strict adherence to ICH, WHO, and international cGMP guidelines ensures consistent quality.
2. Affordable Pricing with High-End Quality Assurance
Taj Pharma ensures:
✔ Competitive export pricing
✔ Long-term supply stability
✔ Strong cost-benefit ratio for tender contracts
✔ International QC testing (assay, impurities, dissolution)
3. Strong Global Supply Chain Presence
With a strong export network spanning 40+ countries, Taj Pharma provides:
-
24/7 export assistance
-
Efficient logistics coordination
-
Door-to-port shipping
-
Multilingual documentation
-
Dedicated account managers
4. Top 20 Countries
USA, UK, South Africa, Kenya, Nigeria, Ghana, Vietnam, Myanmar, Philippines, Bangladesh, Sri Lanka, Iraq, Yemen, Uzbekistan, Kazakhstan, Georgia, Peru, Bolivia, Ukraine, Cambodia
Technical Product Specification Table
| Parameter | Details |
|---|---|
| Product Name | Voglibose + Gliclazide + Metformin Hydrochloride Tablets |
| Strength | 0.2mg + 40mg + 500mg |
| Manufacturer | Taj Pharma India |
| Dosage Form | Film-coated tablet |
| Pharmacopoeia Standard | IP/BP/USP (as per need) |
| Packaging | 10×10 Blister / Alu-Alu |
| Shelf Life | 24–36 months |
| Usage | Oral therapy for Type 2 Diabetes |
| Certifications | WHO-GMP, ISO 9001:2015 |
| Dossier Availability | CTD/ACTD, COPP |
| Export Regions | Africa, Middle East, Asia, CIS, LATAM |
Call to Action
If you are seeking a reliable Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.2mg+40mg+500mg) Manufacturer/Supplier in India, Taj Pharma is your trusted partner.
Why Partner With Taj Pharma?
✔ WHO-GMP certified manufacturing
✔ Best-in-class pricing
✔ Complete regulatory support for global registrations
✔ Custom packaging & private labeling
✔ Fast production & stable supply
📞 Contact Taj Pharma Today
Email: info@tajpharma.com
Website: www.tajpharma.com
Get quotations, samples, product dossiers, or partnership inquiries within 24 hours.
Top 20 FAQs
1. What is this tablet used for?
It is used to treat Type 2 diabetes by targeting multiple mechanisms of blood glucose control.
2. Who is the leading manufacturer of this product in India?
Taj Pharma is the top WHO-GMP certified manufacturer and exporter.
3. Can importers get CTD dossiers?
Yes, complete CTD/ACTD regulatory dossiers are available.
4. Is the product suitable for global tenders?
Absolutely, Taj Pharma regularly supplies to government tenders worldwide.
5. What is the dosage form?
Film-coated oral tablets.
6. What are common side effects?
Hypoglycemia, nausea, diarrhea, headache, dizziness, stomach pain.
7. Can private labeling be done?
Yes, Taj Pharma offers custom branding.
8. What pharmacopoeia standards are available?
IP, BP, USP as per buyer requirement.
9. Is WHO-GMP certification available?
Yes, the manufacturing facility is WHO-GMP certified.
10. What is the shelf-life?
2 to 3 years depending on the region.
11. Does Taj Pharma ship globally?
Yes, to more than 40 countries.
12. What is the minimum order quantity?
MOQ varies; generally starts at 100,000 tablets.
13. How long is the lead time?
Typically 15–25 days after order confirmation.
14. Are stability studies available?
Yes, Zone II–IV stability data is provided.
15. Is it available for PCD franchise in India?
Yes, PAN India franchise opportunities are available.
16. Can it be used long-term?
Yes, under medical supervision.
17. Does Taj Pharma provide COA and test reports?
Yes, each batch comes with complete documentation.
18. Are samples available for registration?
Yes, samples can be provided.
19. Does the medicine need refrigeration?
No, store at room temperature (<25°C).
20. How can I request a quotation?
By emailing Taj Pharma or through their website contact form.






